We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Telstar Promotes Latest Generation of Freeze Dryers in Dubai

By LabMedica International staff writers
Posted on 31 Jan 2019
Telstar (Shanghai, China) displayed the latest generation of compact laboratory freeze dryers at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. More...
The event saw more than 19,610 unique visitors and 678+ exhibitors sharing the most recent technology available in the IVD, and medical laboratory market.

Among its products exhibited at MedLab Middle East 2019 was the Telstar LyoQuest, a bench-top laboratory freeze dryer that combines this breadth of functionality into a single unit so that users can perform complete cycles on a range of sample containers (vials, trays, ampoules, and flasks) using the same piece of equipment. LyoQuest also enables users to create recipes comprising time, temperature and vacuum control via its integrated PLC control system. Its innovative design results in an extremely compact unit with large condensation capacity up to eight liters and enables many product formats to be pre-frozen by the device, without the need for an additional freezer. The LyoQuest’s ice condenser includes an automatic defrosting function for quick and easy de-icing.

The company also promoted the Telstar Bio II Advance Plus compact range of microbiological safety cabinets (MSC) that are intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3. Their innovative cabinet design offers smaller body than the market average while maintaining standard workspace. With dimensions of 759 mm in width and 1260 mm in height, the Bio II Advance Plus provides a working volume of 340 dm3. Equipped to achieve maximum efficiency, this new range of MSC integrates energy saving EC fans and LED illumination that ensures optimum protection levels as well as low energy consumption. Bio II Advance Plus is designed in compliance with the European standards EN 12469 and certified by TÜV-Nord.

Telstar also displayed Boreas, a new -86º ultra-low-temperature freezer designed to increase average performance by 20% and featuring an innovative mechanical design that enhances robustness, efficiency and ergonomics as well as ensures the integrity of the cold preservation process. Equipped with vacuum panels VIP, the freezer guarantees the highest level of thermal insulation and a temperature of -80ºC under an ambient up to +28ºC. Unlike standard freezers designed with panels based on polyurethane foam, a thinner inner insulation provides Boreas with an enlarged storage capacity of up to 30%. Boreas uses high purity natural refrigerant gases to contribute to environment preservation and does not damage the ozone layer. The ecological ultra-low-freezers line has been developed using Telstar’s in-house cold storage technology.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Immunofluorescence Analyzer
IFA System
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.